IRIS
LEONCINI, GIOVANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 10.040
Totale 10.040
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 10.040
Totale 10.040
Salva come PNG Salva come JPEG
Città #
Genova 7.961
Rapallo 1.087
Genoa 959
Bordighera 20
Vado Ligure 13
Totale 10.040
Salva come PNG Salva come JPEG
Nome #
Left ventricular dilatation and subclinical renal damage in primary hypertension 158
Chronic kidney disease in hypertension under specialist care: the I-DEMAND study 147
Increased renal resistive index in patients with essential hypertension: a marker of target organ damage. 146
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 144
Metabolic syndrome is associated with left ventricular dilatation in primary hypertension 136
Ambulatory arterial stiffness index and renal abnormalities in primary hypertension 132
Impact of target organ damage assessment in the evaluation of global risk in patients with essential hypertension. 128
Antihypertensive Treatment and Renal Protection: the role of drugs inhibiting the renin-angiotensin-aldosterone system. 127
Subclinical functional and structural renal abnormalities predict new onset type 2 diabetes in patients with primary hypertension 125
Peripheral artery disease and blood pressure profile abnormalities in hemodialysis patients 125
Cardiovascular and renal effects of hyperuricaemia and gout. 124
Vitamin D modulates the association of circulating insulin-like growth factor-1 with carotid artery intima-media thickness 123
C-reactive protein and target organ damage in untreated patients with primary hypertension. 123
Vitamin D increases circulating IGF1 in adults: potential implication for the treatment of GH deficiency 122
Use of nifedipine in the treatment of hypertension. 121
Creatinine clearance and early signs of target organ damage in primary hypertension 120
Chronic intake of micrograms of abscisic acid improves glycemia and lipidemia in a human study and in high-glucose fed mice 119
Combined effect of albuminuria and estimated glomerular filtration rate on cardiovascular events and all-cause mortality in uncomplicated hypertensive patients 118
Mild renal dysfunction and renal vascular resistance in primary hypertension 117
Combined use of urinary neutrophil gelatinase-associated lipocalin (uNGAL) and albumin as markers of early cardiac damage in primary hypertension. 117
Predicting cardiovascular risk using creatinine clearance and an artificial neural network in primary hypertension 117
Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients 116
Microalbuminuria identifies overall cardiovascular risk in essential hypertension: an artificial neural network-based approach. 115
Severe vitamin D deficiency is associated with frequently observed diseases in medical inpatients 114
METABOLIC SYNDROME AND CARDIOVASCULAR RISK IN PRIMARY HYPERTENSION. 114
Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS 113
Coronary flow reserve is impaired in hypertensive patients with subclinical renal damage 112
5,10-Methylenetetrahydrofolate reductase polymorphism and early organ damage in primary hypertension. 112
Metabolic syndrome and ambulatory arterial stiffness index in non-diabetic patients with primary hypertension. 112
Hyperuricemia and renal risk 112
Overall health assessment: a renal perspective. 111
Inappropriate left ventricular mass is associated with microalbuminuria independently of left ventricular hypertrophy in primary hypertension 111
Renal and cardiac abnormalities in primary hypertension 110
Antihypertensive treatment and renal protection: Is there a J-curve relationship? 109
Blood pressure variability and multiple organ damage in primary hypertension 108
Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertension 105
Elderly Woman With Abnormal ECG 105
Global Cardiovascular Risk Assessment in the Management of Primary Hypertension: The Role of the Kidney 104
Chronic kidney disease and albuminuria in arterial hypertension. 104
Microalbuminuria and subclinical cerebrovascular damage in essential hypertension 103
Mild renal dysfunction and cardiovascular risk in hypertensive patients. 103
Vascular permeability, blood pressure, and organ damage in primary hypertension 103
RAAS Inhibition and Renal Protection 102
Serum uric acid as a marker of target organ damage in primary hypertension 101
SERUM URIC ACID AS A RISK FACTOR FOR CARDIOVASCULAR AND RENAL DISEASE AN OLD CONTROVERSY REVIVED. 99
Antihypertensive Treatment in Diabetic Kidney Disease: The Need for a Patient-Centered Approach 99
Target organ damage and metabolic syndrome in non diabetic hypertensive patients 98
Global risk stratification in primary hypertension: the role of the kidney 98
Sub-clinical organ damage in hypertension and obesity 98
Role of microalbuminuria in the assessment of cardiovascular risk in essential hypertension 98
Microalbuminuria and cardiovascular risk assessment in primary hypertension: should threshold levels be revised? 95
Relationship between vitamin D status and left ventricular geometry in a healthy population: results from the Baltimore Longitudinal Study of Aging 95
MICROALBUMINURIA, CARDIOVASCULAR, AND RENAL RISK IN PRIMARY HYPERTENSION. 94
Microalbuminuria is a predictor of chronic renal insufficiency in patients without diabetes and with hypertension: the MAGIC Study 94
Evaluation of subclinical organ damage for risk assessment and treatment in the hypertensive patient: role of microalbuminuria. 94
Serum uric acid levels predict new onset type 2 diabetes in hospitalized patients with primary hypertension: the MAGIC study. 93
Increased urine semaphorin-3A is associated with renal damage in hypertensive patients with chronic kidney disease: a nested case-control study 93
Metabolic syndrome and microalbuminuria predict renal outcome in non-diabetic patients with primary hypertension: the MAGIC study. 92
Optimizing therapy in the diabetic patient with renal disease: antihypertensive treatment. 92
Increased ambulatory arterial stiffness index is associated with target organ damage in primary hypertension 91
Cardiovascular and renal risk assessment as a guide for treatment in primary hypertension. 91
Left ventricular geometry and function in patients with essential hypertension and microalbuminuria 90
Mild hyperuricemia and subclinical renal damage in untreated primary hypertension 90
Microalbuminuria blood pressure load, and systemic vascular permeability in primary hypertension 89
Pulse pressure and subclinical cardiovascular damage in primary hypertension 89
Mild renal dysfunction and subclinical cardiovascular damage in primary hypertension. 86
Coronary flow reserve is impaired in uncomplicated hypertensive patients with renal dysfunction 86
Microalbuminuria is an integrated marker of subclinical organ damage in primary hypertension. 86
Creatinine clearance and signs of end-organ damage in primary hypertension. 86
Dyspnoea after home improvement work 85
Relationship between inter-arm difference in systolic blood pressure and arterial stiffness in community-dwelling older adults. 84
Mild hyperuricemia and sub-clinical renal damage in primary hypertension 81
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 81
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 79
Chronic kidney disease in the hypertensive patient: an overview of the I-DEMAND study. 78
Looking at the kidney to predict global outcome in the elderly 78
Microalbuminuria in primary hypertension 78
Blood pressure load, vascular permeability and target organ damage in primary hypertension 77
Serum uric acid and target organ damage in primary hypertension. 76
Metabolic syndrome and chronic kidney disease in high-risk Italian hypertensive patients: the I-DEMAND study. 75
Antihypertensive therapy in hypertensive patients with metabolic syndrome. 73
A very low vitamin D threshold, within the range of severe deficiency, identifies an increased risk of non-classical vitamin D-related outcomes in medical inpatients: a role for parathyroid hormone? 73
MICROALBUMINURIA PREDICTS CHRONIC RENAL INSUFFICIENCY IN NON DIABETIC HYPERTENSIVE PATIENTS: THE MAGIC STUDY LONG TERM FOLLOW UP JOURNAL OF HYPERTENSION 72
Serum IGF-I concentration is positively associated with 25-hydroxyvitamin D level and increases upon treatment with vitamin D. 71
Effects of dual inhibition of renin–angiotensin–aldosterone system on cardiovascular and renal outcomes: balancing the risks and the benefits 71
Blood pressure phenotype: an evolving picture 71
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 70
Micro-albuminuria reflects blood pressure load and systemic vascular permeability in primary hypertension 68
Cardionephrology, an emerging discipline: Highlights of the sixth Genoa meeting on hypertension, diabetes and renal diseaseTherapy 66
Optimizing global risk evaluation in primary hypertension: the role of microalbuminuria and cardiovascular ultrasonography. 66
Mild renal dysfunction and subclinical organ damage in primary hypertension 64
Improving cardiovascular risk stratification: the case for redefining microalbuminuria. 61
Subclinal impairment of left ventricular function and extracardiac organ damage in essential hypertension 61
Serum uric acid and its relationship with metabolic syndrome and cardiovascular risk profile in patients with hypertension: insights from the I-DEMAND study 60
7A.09: METABOLIC SYNDROME IS ASSOCIATED WITH LEFT VENTRICULAR DILATATION IN PRIMARY HYPERTENSION 57
Increased renovascular resistance in primary hypertension: A marker of mild renal dysfunction. 54
Uric acid in CKD: has the jury come to the verdict? 50
METABOLIC SYNDROME AND MICROALBUMINURIA PREDICT RENAL OUTCOME IN NON DIABETIC PATIENTS WITH PRIMARY HYPERTENSION: THE MAGIC STUDY Author(s):Source: JOURNAL OF HYPERTENSION Volume: 28 Supplement: A Pages: E25-E26 Published: JUN 2010 49
Ultrasound Doppler renal resistive index: a useful tool for the management of the hypertensive patient 49
null 49
Totale 9.631
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.629
article - articoli 30.247
book - libri 0
conference - conferenze 382
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.258
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.877 122 73 115 182 284 359 435 202 278 447 284 96
2020/20211.047 51 101 104 54 68 73 122 104 90 107 82 91
2021/20221.399 49 82 77 169 54 120 105 324 45 146 58 170
2022/20231.346 128 81 12 146 195 233 41 93 215 53 106 43
2023/2024705 42 83 19 78 71 124 33 43 43 8 55 106
2024/202546 46 0 0 0 0 0 0 0 0 0 0 0
Totale 10.249